Evidence map›Paper›PMID 25089892›Full record

ArticleScientific reports2014

Structural analysis of H1N1 and H7N9 influenza A virus PA in the absence of PB1.

Spencer O Moen, Jan Abendroth, James W Fairman, Ruth O Baydo, Jameson Bullen, Jennifer L Kirkwood, Steve R Barnes, Amy C Raymond, Darren W Begley, Greg Henkel and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Spencer O Moen1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Jan Abendroth1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
James W Fairman1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Ruth O Baydo1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Jameson Bullen1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Jennifer L Kirkwood1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Steve R Barnes1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Amy C Raymond1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Darren W Begley1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Greg HenkelArisan Therapeutics, 11189 Sorrento Valley Rd, Suite 104, San Diego CA 92121, USA.
Ken McCormackArisan Therapeutics, 11189 Sorrento Valley Rd, Suite 104, San Diego CA 92121, USA.
Vincent C TamSeattle BioMed, 307 Westlake Avenue North, Seattle WA 98109, USA.
Isabelle Phan1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Seattle BioMed, 307 Westlake Avenue North, Seattle WA 98109, USA.
Bart L Staker1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Seattle BioMed, 307 Westlake Avenue North, Seattle WA 98109, USA.
Robin Stacy1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Seattle BioMed, 307 Westlake Avenue North, Seattle WA 98109, USA.
Peter J Myler1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Seattle BioMed, 307 Westlake Avenue North, Seattle WA 98109, USA [3] University of Washington, Department of Medical Education and Biomedical Informatics &Department of Global Health, Seattle WA 98195, USA.
Don Lorimer1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Thomas E Edwards1] Seattle Structural Genomics Center for Infectious Disease (SSGCID) [2] Beryllium, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA.
Joint Center for Structural Genomics · USArisan Therapeutics (United States) · USBeryllium (United States) · USNorth Seattle College · US

Funding

NIAID NIH HHS HHSN272200700057CNIAID NIH HHS HHSN272201200025C
6 · The paper itself

Abstract

Influenza A viruses cause the respiratory illness influenza, which can be mild to fatal depending on the strain and host immune response. The flu polymerase acidic (PA), polymerase basic 1 (PB1), and polymerase basic 2 (PB2) proteins comprise the RNA-dependent RNA polymerase complex responsible for viral genome replication. The first crystal structures of the C-terminal domain of PA (PA-CTD) in the absence of PB1-derived peptides show a number of structural changes relative to the previously reported PB1-peptide bound structures. The human A/WSN/1933 (H1N1) and avian A/Anhui1/2013 (H7N9) strain PA-CTD proteins exhibit the same global topology as other strains in the absence of PB1, but differ extensively in the PB1 binding pocket including a widening of the binding groove and the unfolding of a β-turn. Both PA-CTD proteins exhibited a significant increase in thermal stability in the presence of either a PB1-derived peptide or a previously reported inhibitor in differential scanning fluorimetry assays. These structural changes demonstrate plasticity in the PA-PB1 binding interface which may be exploited in the development of novel therapeutics.

Indexed as

Amino Acid SequenceBinding SitesCrystallography, X-RayEnzyme StabilityEscherichia coliGene ExpressionInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H7N9 SubtypeModels, MolecularMolecular Sequence DataProtein BindingProtein Structure, SecondaryProtein Structure, TertiaryRecombinant ProteinsRNA-Dependent RNA PolymeraseViral Proteinsinfluenza virus polymerase basic protein 1PA protein, influenza virusesRecombinant ProteinsRNA-Dependent RNA PolymeraseViral Proteins

Identifiers

PMID25089892
PMCPMC4123200
OpenAlexW1992662340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.